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1. Introduction  
1.1 Pelo Gene 
Pelota (Pelo) is a highly conserved gene, which has been firstly identified in Drosophila 
melanogaster (Castrillon et al.1993). Successive studies have revealed the presence of Pelo in the 
genome of different species from archae to human (Shamsadin et al. 2002). The murine Pelo is 
located on chromosome 13. It consists of three exons, but protein coding sequences are found in 
the second and third exon. Alignments of the predictive amino acid sequences of PELO from 
different species showed a high level of sequence conservation. Thus, the protein sequence 
identity ranged from 55% between mouse and S. cerevisiae and 96% between mouse and human. 
Structural analysis of PELO protein revealed that it consists of three conserved domains. Two 
of them (central and C-terminal domains) are RNA-binding domains and express a strong 
structural similarity to that in the eukaryotic release factor 1 (eRF1). ERF1 has a role in the 
terminal step of protein translation (Davis and Engebrecht 1998). PELO contains Sm-fold 
structure, which serves either to recognize mRNA stem loops or to recruit mRNA decay 
machinery (Tritschler et al. 2007). The N-terminus domain contains a putative nuclear 
localization signal (NLS) (Shamsadin et al. 2002). However, subcellular localization of 
transgenic fusion protein EGFP-PELO in Drosophila was restricted to cytoplasm (Xi et al. 
2005). In fibroblasts of transgenic mouse, the fusion protein EGFP-PELO was localized on the 
cytoskeleton. Results of subcellular localization of Pelo in murine cells were further confirmed 
by Western blotting of protein fractions isolated from membrane, nucleus, cytoskeleton and 
cytoplasm. Immunoblot analysis revealed the presence of Pelo in the membrane and cytoskeleton 
fractions (Burnicka-Turek et al. 2010). 
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In an attempt to identify the potential function of Pelo in mammals Burnicka-Turek et al. 
(2010) has performed yeast two hybrid system to determine the putative interaction partners of 
PELO in human. By screening of prostate cell line, several cytoskeleton-associated proteins as 
HAX1 and SEPX and eukaryotic initiation factor type 3G (EIF3G) were identified. The specific 
interaction of PELO with EIF3G suggests that PELO is involved in protein translation. Further 
studies have revealed that PELO preferentially bound to epidermal growth factor receptor 
(HER2/ERBB2) and this binding opposes the direct interaction of HER2 with the p85, a 
regulatory subunit of PI3K, and thereby attenuating PI3K/AKT signaling in tumor cell lines 
(Pedersen et al. 2014). 
1.2 Biological and molecular role of Pelo 
The function of PELO has been determined by investigation the effect of Pelo mutation on 
cellular proliferation, differentiation and survival in different species. 
1.2.1 Pelo and its homolog Dom34 in yeast 
Characterization of mutant Dom34, a Pelo ortholog in Saccharomyces cerevisiae, revealed 
that the mutation delays the G1 phase of the cell cycle, affects the chromosome segregation, 
decreases the ability to form pseudohyphae significantly and impairs meiotic division, so that the 
mutants produce fewer spore compared to that of wild-type controls. Decreased levels of 
polyribosomal fraction in the extract of mutant dom34∆ suggest that the translation of a subset of 
proteins involved in these processes is specifically affected by Dom34 deficiency (Davis and 
Engebrecht 1998).  
Further characterization revealed that the Dom34 interact with Hsb1 and they are the main 
components of the RNA quality control mechanism which is known as No-Go decay (NGD). 
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During translational elongation, mRNAs with stalled ribosomes at stable stem loop structures, 
rare codons or premature stop codons are targeted by NGD that stimulates the endonucleolytic 
cleavage of mRNA (Doma and Parker 2006; Graille et al. 2008; Chen et al. 2010). Results of in 
vitro experiments using a reconstituted yeast translation system revealed that Dom34 is involved 
in ribosomes recycling by binding to the ribosome A site to promote dissociation of ribosome 
subunits (Shoemaker and Green 2011; Pisareva et al. 2011). Other reports showed that 
Dom34/Hsb1 complex cause dissociation of the stalled ribosomes at 3´end and is also involved 
in  non-stop decay as well as  in decay of non functional 18S rRNA (Cole et al. 2009; Kobayashi 
et al. 2010; Tsuboi et al. 2012).  
1.2.2 Pelo deletion in Drosophila impairs the fertility 
The functional role of PELO was originally studied in D. melanogaster. Mutant male, showed 
normal progression of the four mitotic divisions during germ cell development, however during 
the first meiotic division, the cell cycle is arrested between the premeiotic stages G2-M, therefore 
mutants are sterile. Despite the arrested meiotic division, the resulted Pelo-deficient 
spermatocytes with 4N DNA content continue the germ cell differentiation and form 
spermatozoa-like cells with head and tail structures. On the contrary, meiotic division is not 
affected during germ cell development of mutant females (Eberhart and Wasserman 1995).  
Further study revealed that the balance between self-renewal and differentiation of the gremline 
stem cells (GSCs) in female mutants is disrupted, resulting in sub-fertility. Results of this study 
suggest that PELO represses the expression of differentiation-induced genes in GSCs through the 
activation of bone morphogenetic protein (BMP) signaling and thereby controls its self-renewal 
(Xi et al. 2005). Recently, it has been shown that PELO deficiency in testis and ovary causes up-
regulation of some germline transposones at both transcript and protein levels. These results 
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suggest that the PELO and its interacting partner HBS1 are required for transposone silencing in 
germ cells of Drosophila (Yang et al. 2015). 
1.2.3 Pelo is essential for early embryonic development in mouse 
In mammals, Pelo is ubiquitously expressed in various tissues during embryonic development 
and in adult mice (Shamsadin et al. 2002). Adham et al. (2003) showed that targeted deletion of 
both Pelo alleles by homologous recombination in mice results in embryonic lethality at an early 
post-implantation stage E6.5. Histological analysis of Pelo
-/- 
embryos at embryonic days E6.5 
and E7.5 revealed the presence of all three germ layers. In vitro culture of mutant blastocysts 
showed the failure of the inner cell mass (ICM) to expand after hatching from the zona pellucida 
and to give rise to ESCs. These results suggest that Pelo might be responsible for the regulation 
of the ICM proliferation and differentiation. To circumvent the early embryonic lethality and to 
study the role of Pelo during embryonic development and postnatal life, conditional knockout 
mice have been generated, and we investigated the effect of Pelo deletion on pluripotency and 
differentiation of embryonic stem cells (ESCs) and spermatogonial stem cells (SSCs) and on 
murine development during pre- and postnatal life. 
Temporal deletion of Pelo during early embryonic development revealed that Pelo-deficient 
embryos at 4-cell stage to blastocyst-stage and its ICMs are able to proliferate, but after hatching 
(E3.5-E4.0) the growth of ICM is arrested. Surprisingly, depletion of Pelo after E5.5 did not 
affect the proliferation of the ESCs. These results led us to speculate that PELO is neither 
required for embryonic development till blastocyst stage nor for the ESCs proliferation, but is 
required for the developmental processes occurring between embryonic days 4.0 and E5.5. 
Further experiments revealed that Pelo is essential for the extraembryonic endoderm (ExEn) 
development, which normally occur between E3.5-E4.5 (Nyamsurem et al. 2014).   
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1.3 Pelo in Embryonic stem cell pluripotency and differentiation  
Embryonic stem cells can be obtained from the ICM of pre-implanted embryos and have 
unlimited capacity for self renewal. ESCs are also capable of giving rise to all germ layers and 
their derivative cell types, which makes them a precious source for tissue replacement and repair 
(Martin 1981). Understanding the main regulators of ESC pluripotency and differentiation is 
crucial for improving the somatic cell reprogramming, which have critical therapeutic 
applications in the regenerative medicine (Thomson et al. 1998). 
ESCs maintain pluripotency by multiple regulators in the form of transcription factors, among 
them Oct4, Sox2, and Nanog, as well as leukemia inhibitory factor (LIF), BMP and Wnt/ β-
catenin signaling pathways. Involvement of PI3K/AKT, Foxo1 and VitaminA/Retinol signalings 
in the regulation of stemness has been recently proposed (Zhang et al. 2011; Khillan 2014). 
Recent studies have enabled the construction of regulatory networks between these signaling 
pathways in ESCs that provide a foundation for understanding ESC self- renewal and 
differentiation (Lee et al. 2009). 
 To determine pluripotent potential of Pelo-null ESCs and the cause of impaired ExEn 
development, ESCs were isolated from Pelo
F/-
 blastocysts and Pelo
F
 allele was recombined 
(Pelo
∆
) by treatment of Pelo
F/- 
ESCs with Tamoxifen. The differentiation potential of Pelo-null 
ESCs was investigated in embryoid bodies (EBs) and in teratoma assay. Mutant ESCs exhibited 
infinite proliferation capacity in culture, however they displayed slightly lower growth rate 
compared to control ESCs. Despite Pelo-null ESCs have the capacity to differentiate to all three 
germ layers in vivo teratoma assay, mutant ESCs were not able to differentiate to ExEn in EBs. 
Analysis of expression profile of genes, which are expressed at different time points of EXEn 
development, revealed that the development of ExEn was initiated in Pelo-null EBs, but could 
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not be maintained to the late stages of EB formation. Further experiment revealed that retinoic 
acid (RA) rescue the development of ExEn in mutant EBs. Molecular analysis showed that the 
decreased activity of BMP signaling was the underlying cause for the impaired differentiation of 
ExEn in Pelo-deficient EBs (Nyamsurem et al. 2014). 
1.4 Pelo in Spermatogonial stem cells development 
The first wave of spermatogenesis arises from the gonocytes that are the precursors of 
spermatogonial stem cells (SSCs), whereas the subsequent waves are directly derived from SSCs 
(Yoshida et al. 2006; Raju et al. 2015). Maintenance of male germ cell production throughout the 
life time of an individual is the result of tightly controlled balance between SSC self-renewal and 
differentiation (Oatley et al. 2006; Raju et al. 2015).  
To determine whether PELO deficiency affects the self-renewal and differentiation of germ 
stem cells, we have deleted Pelo during embryonic and adult life. We found that deletion of Pelo 
in adult mice resulted in a complete loss of whole male germ cell lineages after 45 days of 
deletion. Further analyses revealed that the Pelo is required for maintenance of spermatogonial 
stem cells, but dispensable for the development of later stages of spermatogenesis. Depletion of 
Pelo during embryonic development showed that Pelo is not essential for maintaining the 
embryonic gonocytes, but is essential for transition of the gonocytes to SSC (Raju et al. 2015).  
Molecular analysis suggested that Pelo negatively regulates the PI3K/AKT signaling pathway. 
The enhanced activity of PI3K/AKT and subsequent Foxo1 inhibition are responsible for the 
impaired development of SSCs in Pelo-null testes. 
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1.5 Epidermal homeostasis 
Skin is the largest organ in the body, composed of three layers called the epidermis, the 
dermis, and the hypodermis. The epidermis, the outer layer of the skin, serves as the first 
physical barrier that protects the body from fluid loss and entry of toxic and pathogenic agents. 
The dermis is the second skin layer contains nerve endings, sweat and oil glands, hair follicles, 
blood vessels and nerves. The hypodermis is just below the dermis, and consists of fat. In mice, 
the development of the epidermal barrier is initiated at embryonic day 16.5 (E16.5) and must be 
accomplished before the end of gestation (Hardman et al. 1998). Disruption or delay in the 
acquisition of the epidermal barrier is known to result in neonatal lethality (Segre 2006). 
Barrier function is conferred by the outer layer of epidermis, the stratum corneum, as it 
provides a rigid but flexible support to terminally differentiated keratinocytes in the cornified 
layer (Kalinin et al. 2002). The epidermal barrier is maintained by a balance between 
proliferation of self-renewing stem cells located in the basal layer and differentiation of their 
daughter cells (Blanpain and Fuchs 2006). Keratinocyte is the most abundant cell type in the 
epidermis, which synthesizes the major structural components of the epidermal barrier through a 
programmed process of differentiation. Basal keratinocytes arise at the innermost layer of the 
epidermis, after cell division, some progeny remain in the basal layer as stem cells and express 
specific keratin proteins, K5 and K14, while others migrate into the upper epidermal layers 
(Fuchs 2007). 
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Figure 1. Schematic diagram of the skin architecture. Skin is characterized by two main components, 
epidermis and dermis separated by a basement membrane. The epidermis is constituted by a lower basal 
layer which contains a quiescent population of undifferentiated basal cells reserved for regeneration, they 
progressively differentiate in to the spinous layer, granular layer, and finally the outermost cornified layer 
(envelope), which is responsible for the vital barrier function of the skin (Adapted from Hoffjan and 
Stemmler 2007).  
 
During migration the cells change dramatically both biochemically and morphologically they 
differentiate to suprabasal cells expressing a different set of keratin proteins, K1 and K10, then 
granular cells expressing markers of late differentiation, such as loricrin, and finally, become 
flattened enucleated cells of the stratum corneum (SC). Besides the loss of the nucleus and other 
organelles, the aggregation of keratin intermediate filaments (IF) into macrofibrils and the 
formation of a cornified cell envelope (CE) are the major structural changes that occur during the 
differentiation of granular to cornified cells. Filaggrin (Flg), a protein associated with late 
epidermal differentiation, promotes the assembly of keratin IF to form macrofibrils in the 
cornified cells (Irvine et al. 2011). Filaggrin is synthesized as a high molecular weight precursor 
protein called profilaggrin that consists of tandem filaggrin repeats and is stored in keratohyalin 
granules of granular cells as highly phosphorylated proteins (Sandilands et al. 2009). Profilaggrin 
is dephosphorylated and proteolytically cleaved into filaggrin monomers that are released into 
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the lower layer of the SC. Mutations in the Filaggrin gene or genes encoding proteins that 
regulate the post-translational modification of profilaggrin and its processing to mature filaggrin 
lead to disruption of the epidermal barrier and development of skin disorders (Fallon et al. 2009). 
 
Figure 2. Schematic representation of the profilaggrin processing. Within the granular layer, 
profilaggrin is stored as a highly phosphorylated, inactive and insoluble form within keratohyalin 
granules. Profilaggrin is dephosphorylated in the upper most SG. The linker sequence that connects each 
filaggrin monomer is then cleaved to produce filaggrin intermediates (2DI and 3DI). Further proteolysis 
occurs and the released filaggrin monomers bind directly to keratin filaments, causing their collapse into 
thickened and aggregated keratin filaments. In the upper SC filaggrin is released from keratin and further 
degraded to form free amino acids, which act as a natural moisturising factor (Adapted from Matsui et al. 
2011). 
 
Several signaling pathways are involved in mammalian skin barrier development. The role of 
PI3k/Akt signaling during epidermal barrier acquisition has been recently studied. AKT is a 
Ser/Thr kinase and downstream mediator of the phosphatidylinositol 3-kinase pathway 
regulating cell survival, differentiation and growth factor responsiveness. Activation of AKT is 
antagonized by the PTEN, which dephosphorylates PIP3 and thereby inhibits PI3K/AKT-
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mediated survival signaling (Leslie and Downe 2004). Peng et al. (2003) showed that mice 
lacking both AKT1 and AKT2 die postnatally, probably due to lack of epidermal barrier 
function. Additionally O'Shaughnessy et al. (2009) reported that epidermal barrier acquisition in 
late embryonic development is accompanied of AKT activation. 
The BMP pathway has a role in skin development and postnatal skin remodeling. BMP 
ligands and receptors are differentially expressed in the embryonic epidermis (Botchkarev and 
Sharov 2004). BMPs function by binding type 1 (BMPR1A and BMPR1B) and type 2 (BMPR2) 
transmembrane serine/threonine kinase receptors, resulting in phosphorylation of the intracellular 
proteins Smad 1, 5, and 8. Disruption of BMP signaling has been implicated in an array of skin 
disorders (Kan et al. 2011). However, still limited information is available regarding BMP 
signaling in epidermis development and homeostasis. Moreover previous reports have suggested 
that other kinase pathways participate in BMP signaling, including the c-Jun N-terminal kinase, 
phosphatidylinositol 3-kinase (PI3K) and Wnt signaling pathways (Lee et al. 2009). 
1.6 Aim of the study 
 I.  The first aim of this study was to determine whether the impaired development of the 
epidermal barrier is the reason for neonatal lethality in Pelo-deficient mice and to identify the 
molecular causes for the disrupted function of epidermal permeability barrier (EPB). 
Experimental approaches devised for this study can be summarized as follows:  
 To determine the cause of neonatal lethality, we temporally deleted Pelo at different time-
points of embryonic development. To investigate the cause of the epidermal barrier 
defect observed in mutant embryos, we analyze the differentiation and proliferation status 
in the skin of Pelo
∆/∆
 embryos starting from E 15.5 till E18.5 by immunohistological 
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analysis. To address whether altered distribution of filaggrin in E18.5 Pelo
∆/∆
 skin is due 
to defect in filaggrin processing, protein blot analysis was performed. 
 To determine whether the failure of epidermal barrier formation in Pelo-null epidermis is 
associated with altered activity of PI3K/AKT and BMP signaling, we determined the 
activity and crosstalk between both signaling pathways in organotypic culture and studied 
the effect of PI3K/AKT- and BMP-inhibitors on the formation of epidermal barrier.  
 To determine the consequence of Pelo deficiency on epidermal barrier of adult, we 
performed immunohistological and molecular analyses on skin of mutant and control 
mice.  
II. The second aim was to study the impaired differentiation of Pelo-deficient ESCs. For this 
study, the following experiments were designed: 
 To check whether the impaired differentiation of mutant ESCs is only occurring during 
the development of EBs, we studied the differentiation efficiency of Pelo
∆/-
 ESCs and the 
effect of retinoic acid on the induction of Pelo
∆/-
 ESCs differentiation as well as the 
underlying molecular mechanism. 
 Study the consequences of Pelo deficiency on the activity of PI3K/AKT and Wnt signal 
pathways in ESCs. 
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Cre ERT2 mice used in this study were generated in the Institute of Human Genetics, 
University of Göttingen (Nyamsuren et al. 2014). 
2.1.2 Antibodies 
List of the antibodies used in immunohistochemical analysis with the providing supplier and 
the working dilution. 
Antibody Provider Dilution  
Alexa Fluor 488 conjugated IgG (rabbit) Life Technologies, Darmstadt 1:250 
Anti-BrdU antibody (rat) Abcam, Cambridge, UK 1:500 
Anti-Filaggrin (rabbit) Covance,USA; PRB-417P 1:100 
Anti-K10 (mouse) Covance, USA; MMS-159S 1:100 
Anti-K14 (rabbit) Covance, USA; PRB-155P 1:100 
anti-Loricrin (rabbit) Covance, USA; PRB-145P 1:100 
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List of the antibodies used in western blot analysis with the providing supplier and the 
working dilution. 
Antibody Provider Dilution  
anti-DAB2 (mouse) BD Transduction Lab, Heidelberg 1:2000 
anti-Filaggrin (rabbit) Covance, USA 1:5000 
anti-Foxo1 (rabbit) Cell Signaling, USA 1:2000 
anti-Oct4 (mouse) Abcam,Cambridge, UK 
 
1:2000 
anti-pAKT(rabbit) Cell Signaling, USA 1:2000 
anti-Pelota (rabbit) Institute of Human Genetics, Göttingen 1:10,000 
anti-pSMAD1/5 (rabbit) Cell Signaling, USA 1:2000 
anti-total AKT(rabbit) Cell Signaling, USA 1:5000 
anti-α-tubulin (mouse) Sigma-Aldrich, Deisenhofen 1:5000 
secondary peroxidase-conjugated 
antibody (mouse /rabbit) 
Sigma-Aldrich, Deisenhofen 1:10,000 
 
List of the antibodies used in ELISA. 
Antibody Provider 
anti-mouse IgE Southern Biotech, USA; 0114-01 
anti-mouse IgE (goat) Southern Biotech, USA; 1110-01 
HRP-conjugated anti-mouse IgE (goat) Southern Biotech, USA; 1110-05 
2.1.3 Chemicals 
List of the chemicals used in this study. 
Name Manufacturer 
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2-Mercaptoethanol Gibco, Eggenstein 
Beetle –juice small kit PJK GmbH, Kleinbilttersdorf 
Bovine Serum Albumine (BSA) Serva, Heidelberg  
BrdU (5-Bromo-2′-deoxyuridine)   Sigma-Aldrich, Deisenhofen  
Chemiluminescent Substrate  Pierce, Rockford, IL 
DAPI Sigma-Aldrich, Deisenhofen                              
Dispase  Sigma-Aldrich, Deisenhofen 
Dithiothreitol  Sigma-Aldrich, Deisenhofen  
dNTPs Invitrogen, Karlsruhe 
EDTA ICN Biomedicals, Eschwege 
Eosin Sigma-Aldrich, Deisenhofen 
Ethanol  Baker, Deventer, NL 
Ethidium bromide                        Sigma-Aldrich, Deisenhofen                              
Eukitt-quick hardening mounting medium Fluka, Neu Ulm 
Glutaraldehyde Sigma-Aldrich, Deisenhofen 
Goat serum PAN-Systems, Nürnberg 
Hematoxylin  Sigma-Aldrich, Deisenhofen 
Milk powder  Roth, Karlsruhe 
Nitrocellulose membranes  Amersham Pharmacia Biotech 
NuPAGE MOPS/MES SDS running buffer Invitrogen, Karlsruhe 
NuPAGE Novex Bis-Tris 4-12% Gel  Invitrogen, Karlsruhe 
Paraffin Carl Roth, Karlsruhe  
Paraformaldehyde Sigma-Aldrich, Deisenhofen 
Penicillin/Streptomycin PAN-Systems, Nürnberg 
Phosphate buffered saline (PBS)  PAN-Systems, Nürnberg 
PMSF Sigma-Aldrich, Deisenhofen                              
Protease inhibitor cocktail  Roche, Mannheim 
Proteinase K Carl Roth, Karlsruhe  
Renilla Glow –Juice Big kit PJK GmbH, Kleinbilttersdorf 
RIPA buffer Millipore, Darmstadt 
RNase Sigma-Aldrich, Deisenhofen 
SDS Serva, Heidelberg 
SeeBlue Plus2 Pre-Stained Standard Invitrogen, Karlsruhe 
Sodium citrate Merck, Darmstadt 
SuperScript II Invitrogen, Karlsruhe 
SYBR Green Qiagen, Hilden  
 
Tamoxifen  Sigma-Aldrich , Deisenhofen 
Toulidine blue   Sigma-Aldrich, Deisenhofen 
Tris base  Sigma-Aldrich, Deisenhofen 
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TRIzol Life Technologies, Darmstadt 
Tween® 20  Carl Roth, Karlsruhe  
Xylene  
 
Carl Roth, Karlsruhe  
2.1.4 Cell culture mediums and chemicals 
List of the cell culture mediums and chemicals used in cell culture. 
Name Manufacturer 
DMEM  Gibco, Eggenstein  
Gelatine  Sigma-Aldrich, Deisenhofen                              
Hydrocortisone Life Technologies, Darmstadt 
Insulin Life Technologies, Darmstadt 
KnockOut™ Serum Replacement  Gibco, Eggenstein  
Leukocyte Alkaline Phosphatase Kit Sigma-Aldrich, Deisenhofen                              
L-Glutamine Gibco, Eggenstein  
LIF  Millipore, Billerica, USA  
Lipofectamine 2000 TM Invitrogen, Karlsruhe 
Lucifer Yellow Sigma-Aldrich, Deisenhofen                              
LY-294002 Sigma-Aldrich, Deisenhofen                              
Mitomycin C Sigma-Aldrich, Deisenhofen 
Noggin Life Technologies, Darmstadt 
Opti-MEM® I + GlutaMAX TM I  Gibco, Eggenstein 
Williams Medium E 
 
Life Technologies, Darmstadt 
2.1.5 Primers 
List of the primers used in this study for genotyping PCR and reverse transcription 







Tgm1 TGTCACCCTCACCAACGTC GACTGTCTCATTACCCCCGA 
Grhl3 AGCCAACCAGAGACGGATC TGGAAGCTCACAGGGTCATT 
KlF4 AACATGCCCGGACTTACAAA TTCAAGGGAATCCTGGTCTTC 
IL4 TCTCGAATGTACCAGGAGCC GGTGTTCTTCGTTGCTGTGA 
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R1     AACGTCAAAGGAGGCGGTCAG 
R2  CCACTTGTGTAGCGCCAAGTG 
HPRT AGCCCCAAAATGGTTAAGGTTGC TTGCAGATTCAACTTGCGCTCAT 
Stra8 TCACAGCCTCAAAGTGGCAGG GCAACAGAGTGGAGGAGGAGT 
2.1.6 Buffers and cell culture mediums 
List of the buffers and mediums used in this study. 
Buffer Composition  
 
Blocking Solution 
(Western Blotting)  
100 mM Tris-HCl, pH 7.5 
0.1 % Tween20 










0.1 mM NEAA 
1 mM Sodium Pyruvate 
0.2 mM 2-ME 
2 mM L-Glutamine 









serum  replacement 
0.1 mM NEAA 
1 mM Sodium Pyruvate 
0.2 mM 2-ME 
2 mM L-Glutamine 
1 mM P/S 
1000 U/ml LIF 
 
Protein Lysis Buffer 
(Western Blotting)  
1 mM PMSF (in isopropanol) 
Protease Inhibitor Cocktai Tablets 
1× RIPA lysis buffer 
 





Transfer Buffer  
(Western Blotting)  
 
 
25 mM Tris-HCl, pH 8.3 








100 mM Tris-HCl, pH 7.5 
0.1 % Tween20 




Cornified envelope buffer 
20 mM Tris-HCl (pH 7.5) 
5 mM EDTA 
10 mM dithiotreitol 
2% SDS 
2.1.7 Equipments 






Incubator for paraffin (60°C)  MWG Biotech, Ebersbach 
Centrifuge 5415D Eppendorf, Hamburg 
Thermomixer 5436 Eppendorf, Hamburg 
Nanodrop 2000 Thermo Scientific, Schwerte 
pH Meter Sartorius, Göttingen 
Semi-Dry-Blot Fast Blot Biometra, Göttingen 
Thermocycler (Advanced Primus 96)  peqlab, Erlangen  
Microscopes  
 Confocal laser scanning microscope 
 Fluorescence microscope BX60 





7900HT Fast Real-Time PCR System  Applied Biosystems Deutschland 
Microplate reader Powerwave 340, BioTek Instruments 
Cell culture plates  
 
Greiner Bio-one, Frickenhausen  
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2.2 Methods 
2.2.1 Temporal deletion of Pelo in mice 
To inactivate Pelo before the development of the skin barrier, pregnant Pelo
F/F 
Cre ERT2 and 
control Pelo
F/F 
mice were injected intraperitonally (i.p) with tamoxifen (TAM) at gestational 






mice, animals were i.p injected with 1 mg Tam for 5 consecutive days. For the local depletion of 




Cre ERT2 mice were topically treated 
with 100 μl of 4-hydroxytamoxifen (4-OHT) dissolved in ethanol at a concentration of 1 mg/ml 
on 1 cm
2
 of tail skin for 5 consecutive days. Skin samples were prepared from Tam-treated 
mutant Pelo
Δ/Δ
CreERT and control Pelo
F/F 
embryos at E15.5, E16.5, E17.5 and E18.5 and from 
adult animals after 60-90 days of the last day of Tam injection.  
All experiments involving mice were performed according to protocols authorized by the 
Institutional Animal Care and Use Committee of the University of Göttingen. (AZ: 33.9-42502-
04-14/1487). 
2.2.2 Histological and immunohistochemical analysis 
Skin samples were dissected from freshly sacrificed embryos and adult mice, fixed in 4% 
paraformaldehyde (PFA) at 4
o
C overnight, dehydrated through a graded ethanol series, 
embedded in paraffin and cut into 5 μm sections. Sections were stained with hematoxylin and 
Eosin (H&E), toluidine blue or subjected to immunofluorescent analysis. Toulidine blue staining 
was performed to detect mast cells and the number of mast cells was counted under the 
microscope at x100 magnification from 4-5 fields for each skin sample from 3-4 different mice 
for genotype. 
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For immunofluorescent staining, skin sections were rehydrated, boiled for 10 min in 10 mM 
sodium citrate antigen retrieval buffer and blocked for 1 h with 10% goat serum in Trisbuffered 
saline at pH 7.4 (TBS). The tissue sections were incubated overnight at 4°C in the primary 
antibody. After washing with TBS, tissue sections were incubated with the secondary antibody 2 
h at room temperature. DAPI was used for nuclear staining. Microscopic images were taken 
using either an A1 or A1R Nikon confocal microscope. Epidermal layer quantification was 
performed using Fiji Image J software. For epidermal layer quantification experiments, sampling 
areas for measurement were taken from the basal layer to the differentiated layer defined by 






2.2.3 Proliferation assay 
Cell proliferation was measured by i.p injection of pregnant mice gestational day 18.5 with 50 
mg/kg BrdU and the embryos were sacrificed 2 h later. Skin sections prepared as described 
above were incubated with anti-BrdU antibody and anti-K14. The numbers of epidermal BrdU 
positive nuclei relative to total number of k14 positive cells in the basal layer were counted at x 
20 magnification in 5-7 microscopic fields per skin sample from 3-4 different mice per genotype. 
2.2.4 Skin permeability staining 
 




embryos at E18.5 as previously described (Hardman et al. 1998).  
2.2.5 Embryonic epidermal explant culture 
Organotypic culture of embryonic skin was performed as described previously (O'Shaughnessy et 
al. 2009). Briefly, pregnant female mice were i.p injected with Tam at gestational day 13.5 and 14.5 
2 Materials and Methods  20 
 
as described previously. Back skin was dissected from embryos at E15.5, rinsed in sterile PBS and 
cultured dermis side down at the air-liquid interface for 48 hours. Explants were cultured in Williams 
Medium E supplemented with 10 μg/ml insulin, 10 ng/ml hydrocortisone, 2 mM L-glutamine, 100 
IU/l penicillin, 100 mg/l streptomycin. To study the effect of down-regulation of AKT and BMP 
signaling pathways on skin development, AKT inhibitor LY-294002 (150 µmol/l) or BMP inhibitor 
Noggin (400 ng/ml) was added to the culture 24 h prior to collection of the explants. Cultured 
explants were divided into portions, one of which was fixed in 4% PFA for immunostaining and the 
other was used for protein extraction. For analyzing barrier function acquisition in skin explants, 30 µl 
of 1 mM Lucifer Yellow was applied to the skin samples and incubated at 37°C for 1 hour before 
fixation with 4% PFA.  
2.2.6 Protein extraction and Immunoblotting 
 
Epidermal sheets were detached from the dermis by digestion with dispase at 4
o
C overnight. 
For protein extraction, the epidermis was homogenized in cold RIPA buffer supplemented with 
protease inhibitor cocktail and 1 mM PMSF. Homogenates were sonicated and centrifuged at 
12000 g for 20 min at 4°C. 
Protein lysates were resolved on 4–12% SDS-PAGE and transferred onto nitrocellulose 
membranes. Membranes were blocked for 1 h with 5% non-fat milk in 0.1% Tween 20 in TBS. 
Blots were probed at 4
o
C overnight with primary antibody, followed by incubation with a 
secondary peroxidase-conjugated antibody. Signals were detected using a chemiluminescent kit 
and an AlphaView image analyzer. Signals were quantified by using AlphaView software; 
Version: 3.2.0 (Cell Biosciences Inc, Santa Clara, CA). 
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2.2.7 Cornified envelope preparation 
Isolated epidermis from E18.5 embryos was cut into 5 mm2 pieces and boiled for 20 min in 
cornified envelope buffer. Cornified envelopes (CEs) were centrifuged at 6000 g, washed in CE 
buffer containing 0.2% SDS, pelleted, and resuspended in CE buffer for microscopic analysis. At 
least 200 CEs were counted for each of the three mutant and control embryos. 
2.2.8 RNA preparation and real time PCR 
 
Total RNAs were isolated using TRIzol reagent, followed by treatment with RNase free 
DNase for 1 h at 37°C and reverse transcribed using the Superscript II first strand kit. 
Quantitative RT-PCR (qRT-PCR) was performed in triplicate on an ABI Prism 7900HT 
sequence detection system using QuantiTect SYBR Green PCR Master mix, following the 
manufacturer’s instructions. RNA expression levels were normalized to hypoxanthine guanine 
phosphoribosyl transferase (Hprt).The primer sequences are listed in 2.1.5. 
2.2.9 Transmission electron microscopy (TEM) 
 
Skin samples were fixed in 2.5% glutaraldehyde in PBS, pH 7.4 for 4 h and embedded in 
Epon resin.TEM was performed on ultra-thin sections (100 nm) stained with uranyl acetate and 
counterstained with lead citrate. Images were taken with a Philips CM10 instrument at 80 kV. 
2.2.10 Enzyme-linked immunosorbent assay (ELISA) for IgE 
Ninty- six well ELISA plates were coated with an immunoglobulin isotype-specific antibody 
to mouse IgE in 50 mM carbonate buffer, pH 9.6. Upon incubation for 3 h at 37°C, plates were 
blocked with 1% BSA in PBS for 1 h at 37°C. Serum samples were diluted from 1:20 to 1:1280 
in duplicate and incubated at 4°C overnight. To calculate immunoglobulin concentrations, 
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purified mouse IgE was diluted from 500 ng/ml to 7.8 ng/ml on each plate as a standard. After 
washing, plates were incubated with a HRP-conjugated goat-anti-mouse IgE for 2 h at 37°C and 
washed again. For colorimetric detection 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic 
acid) was used as a substrate. Absorbance was measured at 450 nm in a microplate reader.   
2.2.11 Cell culture 
ESCs were maintained on Mitomycin C-treated MEF feeder layers in LIF-supplemented 
medium, cells were incubated at 37°C with 5% CO2 in a humidified incubator. For mono-layer 
differentiation, ESCs were plated on gelatin coated plates at a density of 1000 cell per 1 cm2 in 
DMEM medium supplemented with 20% Knockout
TM
 serum replacement, in absence of LIF. 
2.2.12 Alkaline Phosphatase Staining 
Cells were washed with PBS, fixed for 30 sec. with fixation solution (Sigma)  washed with 
PBS, then Cytochemical staining for alkaline phosphatase (AP) activity was performed using a 
Leukocyte Alkaline Phosphatase Kit according to the manufacturer’s instructions. 
2.2.13 Transfections, Luciferase reporter assays 
Cells were plated in 24-well plates at a density of 5 × 10
2
 per well. Transient transfection was 
done using lipofectamine reagent and OPTIMEM I medium according to the supplier's 
instructions with 5 µg of total TCF/LEF luciferase reporter (TOP) and its negative control (FOP) 
plasmids with renilla plasmid as an internal control. After 24-36 h of transfection, luciferase 
levels were assessed using Dual reagent as described in the kit instructions.  
2.2.14 Statistical analyses 
Data were expressed as mean ± SEM. Differences among groups were tested by the Student’s t test 
or two-way ANOVA test when appropriate. A  P value < 0.05 was considered to be significant. 
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3. Results 
To investigate the molecular role of Pelota, Nyamsuren et al. (2014) generated Pelo 
conditional knockout mouse model. The effect of conditional Pelo ablation on the proliferation 
and differentiation of embryonic and spermatogonial stem cells was analyzed (Nyamsuren et al. 
2014; Raju et al. 2015). In the first part of this study we have determined the role of Pelo in 
the epidermal barrier development. 
3.1 Role of Pelo in epidermal barrier acquisition 
During mouse embryogenesis, the development of EPB is initiated at embryonic day 16.5 
(E16.5) and accomplished before the end of gestation (Hardman et al. 1998). Several lines of 
evidence demonstrated that disruption or delay in the formation of the epidermal barrier results 
in neonatal lethality (Plamer et al. 2006; Segre 2006).  
3.1.1 Deletion of Pelo prior to skin barrier formation causes neonatal lethality 










were i.p injected with TAM at different gestational days, E13.5 and E14.5 or E17.5 and E 18.5. 
No progeny were found on the expected delivery days from pregnant females, which were i.p 
injected with TAM at gestational days 13.5 and 14.5. In contrast, pregnant females treated with 
TAM at E17.5 of gestation gave litters, but all mutant pups died between P7 and P14 (Figure 3a, 
b). These results suggested that the neonatal lethality may be due to defect in the function of 
EPB.  
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Figure 3. Schematic diagram describes TAM administration. Pregnant females were treated with 
TAM at different gestational days before (a) and (b) after the start of the EPB development. 
Intraperitoneal injection of pregnant females at E13.5 and E14.5 (n = 24) leads to neonatal lethality and 
no pups could be recovered. (b) TAM administration to pregnant females at gestational days 17.5 and 
18.5 leads to viable pups. However they died within 7-14 days postnatal (n =12).  
 
To address whether the neonatal lethality is due to an impaired formation of the epidermal 




 breeding were i.p injected with TAM at 
gestational stages E13.5 and E14.5, and monitored daily. E18.5 embryos were delivered by 
caesarean section (Figure 4a). The recovered pups were incubated at 37°C and each individual 
embryo was monitored for body weight hourly. After incubation, genotyping PCR was 
performed on the DNA extracting from a small piece of skin. Genotyping analysis revealed the 




pups (Figure 4b). In agreement with this result, Pelo protein 
was not detected in skin extracts from Pelo-null pups by Western blot analysis (Figure 4c). Thus, 
Pelo was efficiently ablated in the skin of Pelo
∆/∆ 
pups.  
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During the incubation time, we observed that Pelo
∆/∆
 skin was erythematous, glossy and 
sticky to the touch (Figure 4d). The body weight of Pelo-deficient embryos decreased gradually 
and all E18.5 Pelo
∆/∆
 embryos died within 5-6 hours of caesarean delivery. In contrast, control 
Pelo
F/F 
pups did not show significant weight changes during the same period (Figure 4e). These 
observations suggest that the decrease in body weight of Pelo
∆/∆
embryos was due to increased 
transepidermal water loss resulting from an impairment of their epidermal barrier.  
3.1.2 Skin barrier defects are responsible for neonatal lethality in Pelo
∆/∆
 pups 





E18.5 embryos were subjected to toluidine blue dye. In contrast to control 
embryos, there was extensive skin penetration of toluidine blue dye in Pelo
∆/∆
 embryos (Figure 
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Figure 4.  Temporal deletion of Pelo prior to the formation of epidermal barrier leads to 
perturbation of the epidermal permeability function and early neonatal lethality. (a) Schematic 
illustration of the TAM administration to the pregnant female mice and the time of embryos collection.  
(b) Genomic DNA was isolated from the skin of E18.5 embryos and subjected to genotyping PCR 
analysis. The presence of a 455-bp fragment of Pelo
Δ
 allele (Δ) and loss of a 376-bp of Pelo
F 
allele (F) in 
mutant skin demonstrates successful Cre-mediated recombination. Note that Pelo
F/F
 embryos did not 
contain the CreERT allele (data not shown). (c) Western blot analysis of epidermal lysates from E18.5 
Pelo
F/F
 and mutant Pelo
Δ/Δ 
pups shows efficient loss of Pelo in Pelo
Δ/Δ
, but the presence of Pelo protein in 
control Pelo
F/F
 littermates. For loading control, the blot was stripped and reprobed with anti α-tubulin 
antibody (TUB). (d) Gross morphology of E18.5 Pelo
F/F
 (left) and Pelo
Δ/Δ 
(right) pups are shown. (e) 
Graph showing the weight loss of Pelo
F/F
 (n = 4) and Pelo
Δ/Δ 
embryos (n = 6) over the indicated time 
period. Body weight over the time are presented relative to that of 0 h and represented as mean ± SEM. 




embryos using toluidine 
blue. 
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To get insight into the underlying cause of EBP defect, histology, differentiation, and 
proliferation status of the skin of Pelo
∆/∆
 embryos from E15.5, E 16.5, E17.5 and E18.5 were 
investigated. Prior to epidermal barrier formation, the histology of Pelo-null skin at E15.5 and 
E16.5 did not reveal any obvious abnormalities compared to control skin. However, after barrier 
acquisition, the skin of mutant embryos at E17.5 and E18.5 displayed increased epidermal 
thickening in some regions (Figure 5). 
 




embryos.  Representative 





 embryos.  Scale bar = 50 µm. 
 
To assess the proliferation status of control and mutant skin, BrdU was intraperitoneally 
administered to pregnant females and 2 h later skin samples of E18.5 embryos were processed 
for immunostaining using anti-BrdU and anti-K14 antibodies. Pelo-deficient epidermis exhibited 
a significant elevation in the number of K14-stained basal cells that incorporated BrdU as 
compared to controls (Figure 6a). Immunohistological analysis did not reveal any differences 
between control and mutant epidermis in expression of the cell layer-specific marker protein, 
basal-K14, subrabasal-K10 and granular cell marker loricrin (Figure 6b). Expression of terminal 
differentiation marker filaggrin (Flg) was first observed in control and mutant granular cell 
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layers at E17.5 (Figure 6b). At E18.5, Flg accumulated in layers of the stratum granulosum (SG) 
and in stratum corneum (SC) of control skin. However, in mutant skin, Flg was present in all 
layers of the SG, but at low levels in the SC (Figure 6b). The low levels of Flg immunostaining 
in the SC led us to assess whether there were any alterations in the cornified envelop (CE) of 
mutant embryos. CEs were isolated from the epidermis of the control and mutant embryos as 
described in the methods. Microscopic analysis showed symmetrical and smooth Pelo
F/F
 CEs. In 
contrast, Pelo
∆/∆
 CEs were rough, irregular and aggregated, indicating an immature state of CEs 
in the mutant epidermis (Figure 6c).  
3.1.3 Impaired epidermal barrier acquisition in Pelo-deficient pups is associated with 
altered profilaggrin processing 
To investigate whether the altered distribution of filaggrin in the epidermis of E18.5 Pelo
Δ/Δ 
pups was due to a defect in filaggrin processing, we performed Wetern blot analysis. As 
expected, protein blot of epidermal protein lysates revealed that profilaggrin was processed to 
filaggrin monomers in the epidermis of E18.5 control embryos. In contrast, high levels of 
profilaggrin derived proteolytic intermediates and almost no filaggrin monomers were detected 
in Pelo-null epidermis. The results from our immunohistochemical and protein analysis 
suggested that the impaired epidermal barrier acquisition in Pelo-deficient pups may be a result 
of altered profilaggrin processing (Figure 6d). Impaired development of the epidermal barrier in 
Pelo-null embryos prompted us to determine the expression levels of several genes encoding 
transcription factors and structural proteins that are involved in barrier establishment, including 
Kruppel like factor 4 (Klf4), Grainy head–like 3 (Grhl3) and Transglutaminase 1 (Tgase1). As 
shown in Figure 6e, expression levels of Klf4, Grhl3 and Tgase1 were significantly higher during 
and after barrier acquisition in control compared to Pelo-deficient epidermis. Collectively, these 
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results demonstrated that the Pelo deletion during embryonic skin formation results in altered 
profilaggrin processing, abnormal CE formation and skin barrier defects, which could be the 




Figure 6. Epidermal skin dysfunction of Pelo-deficient mice is a result of aberrant processing of 





embryos by co-immunostaining using antibodies to BrdU and k14. All BrdU-positive 




epidermis. Scale bar = 40 μm. Histogram 
showing the percentage of BrdU positive nuclei relative to number of k14 positive cells in the basal layer 
(right panel).  Nuclei (blue) were stained with DAPI. More than 400 cells were examined from 3 pups of 
each genotype. Values are expressed as mean ± SEM. *P < 0.05 vs. control. (b) Immunofluorescence of 





sections from E17.5 and E18.5 mice. Scale bar = 100 μm. (c) Morphological appearance of purified 
cornified envelopes (CEs) from control and mutant E18.5 epidermis visualized by phase-contrast light 




epidermal protein extracts. The positions of profilaggrin-intermediates (2x Flg and 3x Flg) and 
filaggrin monomers (1x Flg) are indicated on the left, and the positions of molecular weight markers 
(kDa) are indicated on the right. (e) Quantitative RT-PCR analysis for the expression of epidermal 




epidermis from E16.5 and E18.5. 
Values of expression levels normalized to Hprt are presented as mean ± SEM of three independent 
experiments. Transcript levels of control epidermis were expressed as 1.0. *P < 0.05 vs. control. 
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3.1.4 Impaired epidermal barrier formation in Pelo-null epidermis is correlated with 
increased activity of BMP and PI3K/AKT signaling 
To determine whether the expression of Pelo in skin is correlated with the epidermal barrier 
formation, protein blot analysis of epidermal protein lysates from  control E15.5, E16.5, E17.5 
and E18.5 revealed elevation of Pelo prior to barrier acquisition and significantly down-regulated 
after barrier formation (Figure 7a). These results were further confirmed by studying the 
expression pattern of Pelo transcripts (Figure 7b). These data indicates that the change in the 
levels of Pelo during epidermal barrier formation is regulated at the transcription level and 
reflects the important role of Pelo during the EPB development. 
Pervious results showed the role of Pelo in regulating BMP and PI3K/AKT signaling 
pathways during the differentiation of embryonic and spermatogonial stem cells (Nyamsuren et 
al. 2014; Raju et al. 2015). This knowledge led us to determine the activity of both signaling 
pathways during epidermal barrier formation in skin of control and mutant embryos. We 
investigated the expression levels of phosphorylated isoforms of SMAD 1/5 and AKT, as 
indicators of the activity of BMP and PI3K/AKT, respectively, in control and mutant epidermis. 
Like the expression pattern of Pelo, expression levels of pSMAD1/5 were down-regulated after 
completion of barrier development in control epidermis, but were unchanged in Pelo-deficient 
epidermis (Figure 7c). In agreement with O'Shaughnessy et al. (2009), expression levels of 
pAKT were elevated at the onset of barrier formation at E16.5 and attenuated thereafter in 
control epidermis (Figure 7d). In Pelo-deficient epidermis, expression of pAKT remained at high 
levels even after barrier formation (Figure 7d), indicating that Pelo deficiency leads to persistent 
activation of BMP and PI3K/AKT signaling pathways.  
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Figure 7. Loss of Pelo elevates the activity of BMP and PI3K/AKT signaling pathways. (a)  Protein 
blot analysis of Pelo expression in epidermal protein extracts of control Pelo
F/F 
embryos during skin 
barrier acquisition. Epidermal protein extracts from mutant embryos at E18.5 was used to verify the 
specificity of anti-Pelo antibody. In the right panel, expression levels of Pelo quantified and normalized to 
that of α-tubulin (TUB) are presented. The Pelo protein levels are presented as mean ± SEM of three 
experiments. A.U. indicates arbitrary units. Protein levels in epidermis of E15.5 were expressed as 1.0. *P 
< 0.05 vs. E15.5. (b) Epidermal RNA isolated from control embryos at different embryonic stages and 
adult mice was used to determine the expression levels of Pelo by qRT-PCR. Values of Pelo expression 
levels normalized to Hprt are presented as mean ± SEM of three experiments. Transcript levels in 
epidermis of adult mice were expressed as 1.0. n = 3 embryos per stage. *P < 0.05 vs. adult. (c, d) 




epidermis at different embryonic stages (left panels). In the right panels, expression 
levels of pAKT and pSMAD1/5 normalized to that of total AKT (AKT) and α-tubulin (TUB), 
respectively, are presented. Expression levels presented as mean ± SEM of three experiments. Protein 
levels of control Pelo
F/F 
epidermis at each age were expressed as 1.0. *P < 0.05 vs. control at the same 
developmental stage. 
 
To determine whether the impaired formation of skin barrier in Pelo-deficient embryo is due 
to elevated BMP and PI3K/AKT signaling pathways, organotypic cultures with skin explants 
dissected from E15.5 embryos were performed. Histological analysis of skin explants after two 
days of culture showed the development of SC in control and mutant (Figure 8a). To determine 
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the status of the epidermal barrier acquisition in control and mutant skin explants, we examined 
the diffusion of the fluorescent dye Lucifer yellow in cultured skin explants. The dye retained in 
the upper layer of control explants SC, whereas in mutant explants Lucifer yellow diffused 
through the SC down into the dermal layer (Figure 8b). These results supported our in vivo 
findings and indicate that impaired epidermal barrier acquisition is a result of autonomous 
defects in Pelo-deficient skin and not due to systemic defects of Pelo deficiency. 
To determine whether inhibition of PI3K/AKT signaling can restore epidermal development 
in mutant explants, E15.5 skin explants were cultured for 2 days in the presence or absence of 
PI3K inhibitor LY294002. Although LY294002 was able to significantly attenuate pAKT levels 
in control and mutant explants, these pAKT levels remained significantly higher than the basal 
pAKT levels found in control skin explants (Figure 8c). Indeed, histological analysis revealed a 
failure of SC development in both control and mutant explants in the presence of PI3K inhibitor 
(Figure 8a). Interestingly pSMAD1/5 levels were slightly increased in the LY294002-treated 
skin of both genotypes (Figure 8c). These results highlighted that there could be a cross talk 
between BMP and PI3K/AKT signaling pathways. Next we addressed whether attenuation of 
BMP signaling would impact on PI3K/AKT activity. Skin explants were cultured in the presence 
or absence of noggin, a BMP antagonist. The effectiveness of noggin in inhibiting BMP activity 
was confirmed by decrease in pSMAD1/5 levels in control and mutant skin explants (Figure 8d). 
Upon noggin treatment in mutant explants, we observed a significant decrease in the levels of 
pAKT that are corresponded to basal levels observed in control skin (Figure 8d). Importantly, we 
observed the development of SC in noggin-treated mutant explants (Figure 8a) and proper 
functioning of the skin barrier, as indicated by retention of Lucifer yellow in the upper layer of 
SC (Figure 8b). In contrast, inhibition of BMP signaling in control skin explants disrupted the 
development of SC (Figure 8a) and affected the EPB, as judged by dye diffusion through all 
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epidermal layers and into the dermis of noggin-treated control explants (Figure 8b). In support of 
these results, levels of Flg monomers were markedly attenuated in noggin-treated control skin 
explants, whereas profilaggrin processing was restored and filaggrin monomers were readily 
detected in noggin-treated mutant skin explants (Figure 8e).  
Taken together these results support our conclusion that the restoration of epidermal barrier 
function by noggin treatment in Pelo-deficient pups is accompanied by proper processing of 
profilaggrin. These results also establish a direct link between elevated levels of BMP and 
PI3K/AKT signaling with defective filaggrin processing in Pelo-deficient epidermis.  
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Figure 8. Noggin treatment restores the functional EPB in mutant skin organotypic culture. (a) 




skin explants before (d0) and after culture for 2 days 
(d2), and cultured skin explants in the presence of LY294002 or Noggin. (b) Micrographic images 




skin explants cultured in presence (+) or 
absence (-) of Noggin. Scale bars in a= 20 μm and in b=40 μm. (c, d) Western blot showing pAKT and 




skin explants cultured either 
with (+) or without (-) PI3K inhibitors LY294002 (c) or recombinant Noggin (d). Histograms in right 
panels show the expression levels of pAKT and pSmad1/5 normalized to that of total AKT (AKT) and α-
tubulin (TUB), respectively. Expression levels are presented as mean ± SEM of three experiments. 
Protein levels in untreated skin explants from control embryos were expressed as 1.0 A. U. indicates 
arbitrary units. *P < 0.05, **P < 0.001, ***P < 0.0001 vs. untreated control or mutant. (e) Protein blot 
analysis for profilaggrin processing in protein extracts of skin explants cultured in either presence (+) or 
absence of Noggin (-). The positions of profilaggrin-related protein products are indicated on the left, and 
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3.1.5 Deletion of Pelo after skin barrier formation results in postnatal hyperproliferative 
skin disorder 
To further  analyze  the phenotypic changes in the skin of Pelo
∆/∆
 mice after birth, TAM was 
twice administered to pregnant females on gestational days 17.5 and 18.5 (after the development 
of the skin barrier) to avoid early neonatal lethality (Figure 9a). Obvious defects in the epidermal 
barrier were observed in Pelo
∆/∆
 pups during the first days after birth in the form of severe 
dehydration, scaliness, hair loss, and they died subsequently between postnatal P7- P14 days. 
Histological analyses of skin sections from Pelo
∆/∆
 pups displayed epidermal hyperplasia as well 
as hyperkeratosis and dermal inflammatory cell infiltrate (Figure 9b). Immunohistochemical 
analyses showed increased thickness in all epidermal layers (Figure 9c). 
 




pups. (a) Schematic diagram describes 
Tamoxifene administration to Pelo
F/F
 pregnant mice at gestational days E17.5 and E 18.5 resulted in 
viable pups for 7 to 14 days. (b) Hematoxylin/eosin-stained skin sections from the neck region of control 
(F/F) and mutant mice (∆/∆). Histological analysis of mutant skin showed epidermal thickening, 
hyperkeratosis and inflammatory dermal infiltrate. Scale bars =100 μm (c) Immunohistochemistry with 
different epidermal markers, anti-K14, anti-K10, anti- loricrin and anti-filaggrin, Sections were 
counterstained with DAPI. Scale bars 100 μm. 
 
3 Results  36 
 
3.1.6 Epidermal barrier defect in Pelo-deficient mice leads to hyperkeratosis and 
inflammation 
 To investigate whether impaired barrier function results in increased susceptibility to skin 
inflammation in adult Pelo
∆/∆
mice as showed in other mouse models with a defect in skin barrier 













 mice presented a normal skin appearance (Figure 
10a), whereas the tails and ears skin of Pelo
∆/∆
 mice were scaly. In addition, facial and neck areas 
exhibited alopecia, erythema and ulcerations, which were aggravated by increased scratching 
behavior that worsened with time (Figure 10b). Therefore, Pelo-deficient animals had to be 
sacrificed once these symptoms appeared to minimize suffering. Histological analysis revealed 
marked epidermal hyperplasia, and a compact and hyperkeratotic stratum corneum in the skin of 
Pelo
∆/∆
 mice (Figure 10c and d). The hair follicles were hyperplastic, consistent with the alopecic 
phenotype in Pelo
∆/∆
 mice (Figure 10d). Electron microscopic analysis revealed an enlarged 
corneal epidermal layer with thick, non-condensed and loosely connected corneal sheaths of 
different electron density exclusively in skin sections of adult Pelo
Δ/Δ 
(Figure 11). In addition, a 
massive diffuse inflammatory infiltrate was observed in the dermis of Pelo
∆/∆
 mice as detected 
by a significant increase in the number of mast cells in skin sections stained with Toluidine blue 
(Figure 10e-g).  
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Figure 10. Depletion of Pelo during mouse adult life displays atopic dermatitis-like phenotypes. (a, 
b) Gross morphology of control (a) and mutant (b) mouse after 3 months of TAM administration. 
Alopecia is noticed in the neck region of mutant mice (insert in b). (c, d) Hematoxylin/Eosin-stained skin 
sections from the neck region of control (c) and mutant mice (d) Scale bars (c,d) = 100 μm. (e, f) 




 (f) skin. Arrowheads indicate mast cells with 





animals is represented as mean ± SEM. *P > 0.05. Data represent the number of mast 
cells in 20 microscopic fields from 3 animals per genotype.  
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mice. Epidermis of Pelo
Δ/Δ 
mice presents with thickened over-compacted stratum corneum 
(SC) layers with different electron density and microvesicular inclusions (white arrowheads; b, c). Pelo-
null mice displayed an extended layer of stratum granulosum (SG) layer with nucleated (Nu) cells 
containing many keratohyalin granules (KG) of different sizes (b, e) and containing less electron dense 
material considered immature KG (circled) (e). Desmosomes were detected in the stratum spinosum in all 
mice (f, g). Control skin displayed a distinct small layer of SG with electron dense deposits of keratin (*) 
and KG (a, d). In all TEM images, the epidermal surface is always located at the top of the image. Bars = 
100 nm (a, b), 500 nm; 2 μm (d-g). 
 
To assess whether the inflammatory skin phenotype is a result of impaired keratinocyte 
differentiation, we determined the expression profile of specific markers of different epidermal 
layers. As shown in Figure 12a and b, K14 was expressed in basal cells of control epidermis, 
whereas it extended into the supra-basal cell layers of mutant epidermis and overlapped with 
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expression of the early differentiation marker K10 (Figure 12c and d). Expression of late 
differentiation markers, loricrin and filaggrin, revealed increased layers of SG and SC in mutant 
epidermis (Figure 12e-h) indicating perturbed keratinocyte differentiation is the cause for 
disruption of epidermal barrier function in adult mutants. 
Next, we addressed the origin of the inflammatory phenotype and investigated whether it 
correlated with epidermal hyperplasia and scratching behavior in Pelo
∆/∆
 mice.  Expression 
levels for epidermal IL-4 and TSLP, which are implicated in the pathogenesis of atopic 
dermatitis (Chan et al. 2001; Demehri et al. 2009), were dramatically increased in Pelo
∆/∆ 
epidermis compared to those of Pelo
F/F
 mice (Figure 12i and j). In addition, mutant mice also 
showed increased serum IgE levels when compared to control mice (Figure 12k). 
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immunostained with anti-K14 (A, B), anti-K10 (C, D), anti- loricrin (E, F) and anti-filaggrin (G, H). 
Sections were counterstained with DAPI. Dotted line indicates the epidermal dermal boundary. Scale bar 
= 100 μm. Histograms show thickness of stained layers (right panels). Error bars denote mean ± SEM. 





were determined by qRT-PCR analysis. All values are represented as mean ± SEM. **P < 0.001 




mice using ELISA. All values are represented as mean ± SEM. **P < 0.001 vs. control, n = 3-4 animals 
per genotype. 
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To determine whether the skin symptoms were due to a systemic immune disorder or a 
defective skin barrier, we topically administrated TAM daily for 10 days to a small part of 
Pelo
F/F
 CreERT2 tail skin. As vehicle control, tail skin of Pelo
F/F
 CreERT2 was treated with 
ethanol. Six weeks after topical application of TAM, no obvious alternations were observed in 
vehicle-treated tail skin (Figure 13a), whereas TAM -treated tail skin became thickened and 
scaly. No other sites of the tail or body skin extending beyond the sites of TAM application 
exhibited any skin abnormalities (Figure 13b). Histological analyses revealed hyperplasia in 
these skin lesions (Figure 13c and d).  
 
Figure 13. Topical deletion of Pelo leads to skin defect. Images showing tail skin of Pelo
F/F
CreERT2 
mice were treated by topical application of ethanol as vehicle control (a) or TAM (b). Bracket denotes the 
treated region. The TAM-treated tail region shows thickening and is scaly. (c,d) H&E stained tail skin 
sections of ethanol- (c) and TAM-treated (d) tail regions. Scale bar = 20 μm. 
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3.2 Elucidating the consequence of Pelo deletion on embryonic stem cells 
(ESCs) differentiation 
In this study, we attempted to identify the molecular cause for impaired differentiation of the 
Pelo-deficient ESCs. We wanted to address whether Pelo modulates PI3K/AKT signaling 
pathway as well as  other  related signal cascades e.g Wnt/ß-catenin, which are known to be 
important in  regulating  ESC self-renewal and differentiation (Lee et al. 2009). 
3.2.1 Pelo negatively regulates the PI3K/AKT signaling in ESCs 
Phosphorylation levels of AKT (pAKT) serves as an indirect quantification of the activity of 
PI3K/AKT signaling. To check whether Pelo regulates PI3K/AKT signaling pathway in ESCs, 
we examined the expression of pAKT by Western blot analysis. To avoid the effect of growth 
factors presenting in serum, ESCs were cultured on mouse embryonic fibroblasts (MEF) in 
knock out serum replacement medium (KSR) in absence of leukemia inhibitory factor (LIF), as 
LIF can activate PI3K-AKT pathways (Takahashi et al. 2005). After 24 hours of culture, protein 
extracts were isolated and subjected to protein blot analysis. As shown in Figure 14a, levels of 
phosphorylated AKT protein (pAKT) were significantly increased in extracts of Pelo
Δ/−
 ESCs 
compared to that of control. These results are consistent with our pervious finding that the 
activity of PI3K/AKT in testis is negatively regulated by Pelo (Raju et al. 2015). 
Several growth factors including basic fibroblast growth factor (bFGF) and epidermal growth 
factor (EGF) activate the PI3K/AKT signaling (Nii et al. 2014; Wang et al. 2000). To determine 





 ESCs were cultured overnight in KSR medium lacking LIF and treated with either bFGF 
(20 ng/ml) or EGF (30ng/ml) for 15 min. Immunoblot analysis revealed that the levels of basal 
pAKT were significantly higher in mutant ESC compared with control, and that both bFGF and 
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EGF treatment further enhanced the activity of AKT signaling in mutant and control ESCs 





ESCs were cultured overnight in KSR medium either in presence or 
absence of Wortaminin. As shown in Figure14c, levels of pAKT were significantly decreased 
after the treatment of mutant and control ESCs with Wortaminin. These results indicate that 
enhanced levels of pAKT are induced in PI3K-dependent manner. Taken together, these data 
indicate that Pelo negatively regulates the PI3K/AKT signaling in ESCs.  
 




ESCs. Expression levels of pAKT normalized 




ESCs (a) and (b) in presence (+) or absence (-) of either 
bFGF or EGF. (c) Expression levels of  pAKT in mutant and control of ESCs in absence (-) or presence 
(+)PI3K inhibitor (Wortaminin) at 100−150 nM/ml. Histograms in the  right panels show the expression 
levels of pAKT normalized to that of total AKT (AKT). Expression levels are presented as mean ± SEM 
of three experiments. Protein levels in control (a) and untreated control ESCs (b, c) were expressed as 1.0. 
A. U. indicates arbitrary units. *P < 0.05, **P < 0.001, ***P < 0.0001 vs.untreated control or mutant. 
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3.2.2 Elevated activity of PI3K/AKT is not the cause for impaired differentiation of Pelo-
deficient ESCs 
To elucidate whether increased activity of PI3K/AKT signaling  in mutant Pelo
∆/-
 ESCs is 






 ESCs were 
seeded at a low density and cultured for 12 days in the absence of LIF. The differentiation status 
was examined at different time points by cell morphology, and the expression of alkaline 
phosphatase (ALP) and Oct4, specific markers of undifferentiated ES cells. After 12 days of 
culture, peripheral cells of majority Pelo
F/-
colonies exhibit flatten morphology and did not 
express ALP. In contrast, mutant ESCs retained a low cytoplasm-to-nuclei ratio and formed 
round and multi-layered colonies, which are characteristics of undifferentiated ESCs, and 
expressed high ALP activity even after 12 days of culture under differentiation condition (Figure 
15a).  Expression levels of Oct4 were maintained at high levels in mutant ESCs during 12 day 
culture, while that in control cells was significantly attenuated. These results suggest the 
impaired potential of mutant ESCs for differentiation (Figure 15b). 
Recently, it has been reported that inhibition of PI3K/Akt induces differentiation of mouse and 




 ECSs at a low density and 
cultured for 12 days in the absence of LIF and further cultured with and without PI3K inhibitor, 
Wortaminin. Pelo
F/-
 ESCs showed the differentiated phenotype and reduction in Oct4 expression. 
Surprisingly Pelo
∆/-
 maintained self-renewal even after addition of Wortaminin and showed 
elevated Oct4 expression levels (Figure 16a, b). These results suggest that the elevated levels of 
PI3K/AKT signaling are not responsible for the impaired differentiation of mutant ESCs. 
 




Figure 15. LIF-independent maintenance of pluripotency in Pelo
∆/-
 ESCs. (a) Morphology of ESCs 
colonies at day 4, day8 and day12 of culture in absence of LIF. Pelo
∆/-
 ESCs colonies exhibit the 
morphology of undifferentiated cells and expressed high levels of pluripotency-related enzyme ALP. 
Scale Bar = 200µm. (b) Immunoblot for expression of OCT4 in control (F/-) and mutant (∆/-) ESCs 
before (d0) and at different times of culture under differentiation condition. In the Bar graph presented in 
the right panel, expression levels of OCT4 were normalized to that of tubulin (TUB). Values are 
presented as mean ± SEM. **P < 0.001 compared with control.  
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Figure 16. Wortaminin did not induce differentiation in Pelo
∆/-
 ESCs. (a) Morphology of ESCs 
colonies at day 4, day8 and day12 of culture in absence of LIF, with (+) and without (-) 
Wortaminin. Pelo
F/-
 ESCs differentiate spontaneously in absence of LIF as well as in absence of 
LIF with Wortaminin.  Pelo
∆/-
 retained the characteristic features of undifferentiated ES cells 
even after Wortaminin treatment. Scale Bar = 100µm.  (b) Immunoblot showed expression of 
OCT4 in control (F/-) and mutant (∆/-) ESCs before (d0) and at different times of culture under 
differentiation conditions in presence of Wortaminin. The same immunoblot was stripped and 
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3.2.3 Retinoic acid (RA) induces the differentiation of Pelo-deficient ESCs 
RA, the most potent metabolite of retinol, is an important player for the induction of ESC 
differentiation (Gudas 1994). To examine the ability of retinoid signaling to promote the 
differentiation of Pelo-deficient ESCs, all-trans RA (atRA) was added after 12 hours of ESC 




 ESCs were differentiated as judged 
by flatted morphology and induction of Dab2 expression, a specific marker for ExEn (Figure 
17a, b).These results indicates that the impaired differentiation of Pelo-null ESC can be restored 
by RA. Based on the fact that the retinol retains the ESC pluripotency and its final product RA 
induces differentiation, we suppose that the retinol metabolism is affected in Pelo mutant ESCs. 
To prove our suggestion, we checked the expression levels of (stimulated by RA gene 8) Stra8 
(Oulad-Abdelghani et al. 1996). Expression levels of Stra8 were significantly high during 
differentiation in control ESCs. In contrast, Stra8 expression levels in Pelo
∆/-
 ESCs were low on 
the basal level d0 and even become lower during differentiation (Figure 17c). Collectively, these 
results indicate defect in the retinol metabolism in Pelo-null ESCs, judged by low Stra8 levels, 
leading to defect in ESCs differentiation.  
3.2.4 Crosstalk of Foxo1 with β-catenin may be the cause for sustained expression of 
pluripotent-related genes and impaired differentiation of mutant ESCs 
FOXO proteins are negatively regulated by AKT (Brunet et al. 1999). It was reported that Foxo1 
regulates Rdh expression, which catalyze the retinol metabolism (Obrochta et al. 2015). To 
address whether Foxo1 function is affected in Pelo
∆/-
 ESCs, ESCs were cultured under 




 ESCs were 
isolated at different time points and subjected to immunoblotting using anti-Foxo1 antibody 
(Figure 18a). 
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Figure 17. Retinoic acid induces differentiation of Pelo
∆/-
 ESCs (a) ESCs morphology at d4, d8 and 
d12 of culture in absence of LIF and with (+) or without (-) of atRA (1 μM/L). RA induces differentiation 





ESCs at different times of culture in presence of RA. (c) Quantitative RT-PCR analysis for the expression 
of stra8 in Pelo
F/-
 ESCs and Pelo
∆/-
 ESCs at different times of culture in absence of LIF. Values were 
normalized to Hprt and are presented as mean ± SEM of three independent experiments. Transcript levels 
of control ESCs d0 were expressed as 1.0. **P < 0.001, ***P < 0.0001 vs. control. 
 
Nuclear accumulation of Foxo1 in Pelo
F/−
 ESCs at d4 of differentiation was significantly lower 
than that in mutant cells and depleted thereafter. In contrast Pelo
∆/-
 ESCs showed persistent 
Foxo1 nuclear localization after different time points of culture under differentiation condition 
(Figure 18a). These results interfere with our expectation that activation of PI3K/AKT in mutant 
ESCs induce phosphorylation and nuclear exclusion of Foxo1. However, our results were in 
agreement with Zhang et al. (2011) finding, which showed the nuclear localization and 
transcriptional activation of Foxo1 despite its phosphorylation by AKT pathway. Recent studies 
identified Foxo1 as a novel interacting partner of β-catenin (Essers et al. 2005). The direct 
interaction between β-catenin and FOXO1 leads to their nuclear accumulation and enhances 
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FOXO transcriptional activity. On the other hand, FOXO competes with TCF for interaction 
with the β-catenin, thereby inhibiting TCF transcriptional activity (lyer et al. 2013). To check 
whether nuclear accumulation of Foxo1 in Pelo-deficient ESCs results in inhibition of TCF 
transcriptional activity, control and mutant ESCs were transiently transfected with luciferase-
based β-catenin/TCF (TOP/FOP-FLASH) reporters. In the TOP- and FOP-FLASH reporter, the 
luciferase gene (Luc) under the control of promoter contains multiple copies of optimal and 
mutant TCF binding sites, respectively. The relative TOP-Luc activities were significantly lower 
in Pelo-deficient ESCs than that in control cells (Figure 18b), indicating the inhibition of TCF 
transcriptional activity in mutant cells. These results suggest that nuclear accumulation of Foxo1 
in Pelo-deficient ESCs may be responsible for the sustained expression of pluripotent-related 
genes even during culture in differentiating conditions. Furthermore, decreased TCF 
transcriptional activity in mutant cells may explain the observed decrease in proliferation 
capacity of mutant ESCs. This finding has to be confirmed by analysis the expression of cyclin-
D1, a marker of cell division and a target of TCF gene activation (Shtutman et al. 1999). 
 
Figure 18. Nuclear localization of Foxo1 in Pelo
∆/- 
ESCs is associated with low β-catenin/TCF 





ESCs at different times of culture under differentiation condition. Anti-Histone 3(H3) was used as a 
loading control. (b) Cells were transfected with pTOP glow or pFOP glow, together with Renilla as an 
internal control; luciferase activity was measured after 36 h. The ratio of TOP over FOP is plotted. Data 
presented are mean ± SEM. ***P < 0.001 compared with control of three independent experiments.  
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4. Discussion  
4.1 Pelota is required for the epidermal barrier acquisition 
The epidermal permeability barrier is a specialized structure that protects the skin from 
dehydration, entry of chemical or infectious agents, thereby it is essential for the extra-uterine 
life. Formation of the permeability barrier is a highly patterned process that begins at E16 in the 
mouse and is completed by birth (Hardman et al. 1998). In the epidermis, there are multiple 
components, which are important for the barrier function. These components include claudin, 
filaggrin, proteases, ceramide and desmoglein (Table 1). When properly functioning, this layer 
prevents water loss and provides a barrier to epidermal invasion of allergens and bacteria (Hogan 
et al. 2012).  
Several mouse models with mutations in the genes of the stratum corneum lead to disruption 
of the epidermal barrier and development of skin disorders resulting in neonatal lethality. Further 
reports showed that defects in proteins, which are involved in lipid transport and secretion, affect 
as well the epidermal permeability barrier function (Segre 2003; Leyvraz et al. 2005; Herrmann 
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Table 1. Functions of epidermal barrier components (Adapted from Hogan et al. 2012). 
Barrier component Type Function 
Claudin Tight junction 
protein 



















Cornified cell envelope formation. 
lipoxygenase3, 12R- 
lipoxygenase, CYP4F22, 
ichthyin and steroid sulfatase 
              
               Lipid 
 




               
Lipid 
 
Lipid transport in lamellar 
ranules. 




Prevention of protease activity in 







Contribution to skin  permeability 















Structural components of 
epidermal barrier 
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The present study showed that the expression pattern of Pelo is prior to the skin barrier 
development indicating its relevant role in the barrier formation. Temporal loss of Pelo prior to 
the acquisition of a functional epidermal barrier results in neonatal lethality. Pelo mutant 
embryos died within 6 hours of cesarean section, presumably because of increased 
transepidermal water loss. This assumption was proved by dye penetration assay, which revealed 
intense penetration of toluidine blue dye through the epidermis of Pelo mutant embryos. 
Histologically, the Pelo-null epidermis showed thickening in some regions as a result of 
increased proliferation rate of the epidermal stem cells.  
Defects in the epidermal differentiation or cornification result in diverse clinical disorders 
which are classified as ichthyosis. The perturbation in the balance between epidermal 
proliferation and differentiation does typically result in barrier deficiency (Serge 2006). Severe 
congenital ichthyosis are mainly due to mutations in genes encoding proteins that are involved in 
the synthesis and transport of lipids and that regulate the expression and maturation of structural 
proteins of the CE (Richard 2004). To date, the genes identified and found to be the cause for 
ichthyosis in human patients are shown in Table 2. Most ichthyosis phenotypes mentioned below 
exhibit a primary abnormality in the stratum corneum and associated with the barrier dysfunction 
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Table 2. Genetic causes of epidermal barrier defects in Human ichthyosis (Adapted from Akiyama 
2011) 










Keratin 1 KRT1 AD 
Epidermolytic 
ichthyosis 




keratin 2 KRT2 AD 
Cornified cell 
envelope 
CIE/LI TGase 1 TGM1 AR 
Intercellular lipid 
layers 
Harlequin ichthyosis ABCA12 ABCA12 AR 
LI or CIE lipoxygenase-3  ALOXE3 AR 
 LI or CIE 12R-
lipoxygenase 
ALOX12B AR 
AD, autosomal dominant; AR, autosomal recessive; ASD, autosomal semidominant; CIE, Congenital 
ichthyosiform erythroderma; LI, Lamellar ichthyosis. 
 
Profilaggrin is a heavily phosphorylated protein that is stored in keratohyalin granules of 
granular cells (Dale et al. 1985). The phosphorylated character of profilaggrin is thought to 
prevent its premature processing to filaggrin monomers. Thus, only dephosphorylated filaggrin 
monomers have keratin-filament-aggregating properties (Lonsdale-Eccles et al. 1982). The 
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phosphorylation sites in the profilaggrin are mainly located in the linker peptides between 
filaggrin repeats and considered to be the recognition sites of cleavage enzymes (Sandilands et 
al. 2009). Multiple kinases including AKT, protein kinase A/protein kinase G/protein kinase C 
(AGC), PKC and CAMK2 have been identified to be responsible for the post-translational 
phosphorylation of profilaggrin (Figure 19). A general decrease in phosphorylation of 
profilaggrin is thought to be required before its proteolytic processing into filaggrin monomers 
(Resing et al. 1993). The monomeric filaggrin is then secreted into the transitional zone between 
the granular and cornified layers, where it is involved in the assembly and cross-linking of 
keratin filaments (Dale et al. 1978). Analysis of Pelo-deficient skin revealed abnormal 
distribution of filaggrin-immunoreactive staining in the epidermal layers, absence of filaggrin 
monomers and enlarged keratohyalin granules in granular cells of mutant epidermis. These 
findings indicate that Pelo directly or indirectly regulates the processing of profilaggrin into 
filaggrin monomers during terminal differentiation of corneocytes and that is the main 
underlying cause for the barrier disruption.  
 
Figure 19. Schematic illustration of Protein kinases that might target profilaggrin and the predicted 
sites of phosphorylation. PKB/Akt, protein kinase B; CDK5, cyclin-dependent kinase 5; Y-kinase, 
tyrosine kinase; DNA-PK, DNA-dependent protein kinase; GSK3, glycogen synthase kinase 3; 
AGC/CAMK kinases, members of the AGC and CAMK kinase families (Adapted from Sandilands et al. 
2009). 
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Analysis of different mouse models with ichthyosis revealed that either mutations in genes 
encoding for profilaggrin or protein involved in its proteolytic processing are linked to 
alterations in barrier integrity (Leyvraz et al. 2005; List et al. 2003; Fallon et al. 2009; Hoste et 
al. 2011). The most striking examples are the mice lacking the serine proteases matriptase (MT-
SP1) (List et al. 2003) or prostasin (Prss8) (Leyvraz et al. 2005). Both the matriptase- and 
prostasin-deficient mice show impaired development of the epidermis, which is accompanied by 
a defective skin barrier function that results in neonatal lethality. Both mice show defects in the 
profilaggrin-to-filaggrin processing pathway. 
For more characterization of the skin barrier defect in Pelo-null embryos, we evaluated the 
expression pattern of, Grainy head–like 3 (Grhl3), Transglutaminase 1 (Tgase1) and Kruppel 
like factor 4 (Klf4) genes. These genes encode transcription factors and structural proteins that 
have critical role in barrier establishment. Mice lacking Grhl3 fail to form an adequate skin 
barrier and die at birth due to dehydration. These defects are resulted in part, to diminished 
expression of a Grhl3-targeted gene, Tgase 1, which encodes a key enzyme involved in cross-
linking of epidermal structural proteins and lipids into the cornified envelope. Additionally, Ting 
et al. (2005a) identified defect in the extracellular lipid processing as well as altered lamellar 
lipid architecture. There was a marked similarity between mice lacking Grhl3 and Klf4-deficient 
animals (Ting et al. 2005b). Our expression analysis showed significant attenuated levels of Klf4, 
Grhl3 and Tgase1 in Pelo-deficient epidermis compared to the control during and after barrier 
formation. Therefore, it is of interest to address the relationship between Pelo and these 
epidermal barrier-related genes. 
The consequence of Pelo deletion in the postnatal and adult life revealed that the perturbation 
of epidermal barrier function manifested by dermal infiltration of immune cells, epidermal 
hyperplasia and defective terminal differentiation of keratinocytes. Similar phenotype was 
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observed upon topical deletion of Pelo in the tail providing evidence that the barrier defect is 
rather a skin-autonomous effect. 
4.2 Pelo regulates BMP and PI3K/AKT signaling pathways during barrier development 
Many reports indicate the essential role of PI3K/AKT signaling in the barrier formation. 
O’Shaughnessy et al. (2009) found that a ‘pulse’ of AKT activity is coincident with the barrier 
acquisition in the mouse embryo. Another study from the same group showed that Akt activation 
is prerequisite for HspB1 intracellular relocation. HspB1 transport to the keratohyalin granules 
and its association with keratin filaments is probably necessary for processing of critical SC 
proteins like filaggrin (O’Shaughnessy et al. 2007). As mentioned above, AKT is suggested to be 
one of the Protein kinases that might target Profilaggrin (Sandilands et al. 2009).  
The BMP pathway is another important pathway involved in the skin development. 
Botchkarev and Sharov (2004) descriped the expression pattern of type I BMPreceptors (BMPR-
IA and BMPR-IB) in the basal and the suprabasal layers the epidermis respectively. These 
results indicate the relevant role of BMP signaling pathway in the epidermal development.  
Moreover, elevated activity of BMP signaling in the epidermis leads to enhanced K6 expression, 
increase cell proliferation rate and affect the filaggrin expression (Yu et al. 2010). 
Previous reports have revealed that Pelo mediates many cellular processes through regulation 
of BMP and PI3K/AKT signaling pathways (Raju et al. 2015; Nyamsuren et al. 2014; Pedersen 
et al. 2014). Considering these knowledge, it was very important to emphasize the presence of 
crosstalk between Pelo and these two signal pathways during the barrier development. 
Expression pattern of Pelo during epidermal barrier formation showed similar kinetics to the 
activity levels of PI3K/AKT and BMP signaling pathways. Further results showed a significant 
elevation in the activity of both signaling pathways in the absence of Pelo, leading us to the 
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conclusion that Pelo negatively regulates BMP and PI3K/AKT signaling pathways during 
development of the epidermal barrier. Moreover, in vitro studies on control and mutant skin 
explants showed that inhibition of PI3K/AKT signaling resulted in a significant decrease in the 
levels of pAKT, which leads to impaired development of the SC in both control and mutant skin 
explants. These results corresponds to the findings of Peng et al. (2003), which showed that the 
disruption of the development of the SC and subsequent neonatal lethality were a result of 
attenuated PI3K/AKT activity in double null mice Akt1 and Akt2. Although the levels of pAKT 
in mutant skin are being attenuated by LY294002-treatment, the development of epidermis was 
not restored. These results suggest that loss of Pelo may affect other signaling pathway(s) 
necessary for normal skin development. One of the most striking observations was the increase 
in the pSmad expression levels upon attenuation of pAKT by LY294002-treatment highlighting a 
relationship between BMP and PI3K/AKT signaling in skin development. Recently, BMP has 
been found to be a regulator of PI3K/AKT pathway during the development of different tissues 
(Ghosh-Choudhury et al. 2002; He et al. 2004; Sui et al. 2009). Based on these findings, we 
assumed that Pelo either directly or indirectly modulates BMP activity, which subsequently 
regulates PI3K/AKT signaling. This assumption was further confirmed by decrease in the levels 
of pSMAD and pAKT upon treatment of the skin explants with BMP antagonist Noggin. The 
restoration of epidermal permeability barrier in the mutant explants after attenuation of 
PI3K/AKT activity upon Noggin treatment suggest that increased AKT activity might be the 
cause of the impaired processing of profilaggrin . 
To date the cross link between AKT and profilaggrin processing is not completely understood. A 
general decrease in phosphorylation levels of profilaggrin is thought to be required before its 
being processed into filaggrin monomers (Resing et al. 1993). PI3K/AKT signaling mediates the 
phosphorylation of many proteins including proteins that are involved in epidermal barrier 
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acquisition (O'Shaughness et al. 2007; O'Shaughnessy et al.  2009). Regarding this knowledge, 
we suggest that the significant elevation of pAKT in Pelo-depleted epidermis might counteract 
the dephosphorylation of profilaggrin and its processing. 
 We showed that the defective barrier function in Pelo-deficient mice is associated with a 
significant increase in cell proliferation in the basal layer of epidermis and defect in the terminal 
differentiation of keratinocytes. The defect in the between differentiation and proliferation might 
be responsible for the perturbation of epidermal barrier acquisition. Certainly, it is still highly 
questionable; How Pelo modulates the activities of both signaling pathways during epidermal 
barrier development? 
In conclusion, our results point out that Pelo is a novel modulator of the BMP-PI3K/AKT 
signaling axis which promotes the maturation of profilaggrin to ensure epidermal barrier 
formation. 
4.3 Do PELO mutations in humans cause Ichthyosis Vulgaris? 
Ichthyosis vulgaris (IV) is one of the most common types of ichthyosis with an estimated 
incidence of 1 in 250-1000 births (Bremmer et al. 2008). Ichthyosis vulgaris is inherited in a 
semidominant manner with 83–96% penetrance (Oji et al. 2009). Clinically, IV is characterized 
by xerosis, scaling, keratosis, palmar and plantar hyperlinearity, with a strong predisposition to 
atopic disorders. Loss-of-function mutation in the FLG is identified as one of the major cause for 
IV (Sandilands et al. 2007). 
Chen et al. (2008) evaluated a cohort of eight unrelated Singaporean Chinese IV patients. One 
Patient out of eight exhibited a severe IV phenotype and showed complete absence of filaggrin 
staining, but no mutation was detected. Another study found that FLG null mutations were 
present in 74% of 54 patients with isolated IV and 43% of 116 patients with AD-associated IV. 
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All six patients with AD with or without FLG mutations were demonstrated to suffer from 
epidermal barrier dysfunction (Li et al. 2013). The authors speculated that, it is possible that IV 
patients without filaggrin mutations could have mutations in another unknown gene that plays a 
critical role in the regulation of filaggrin expression, leading to the ichthyosiform phenotype.  
Considering this knowledge from the literature and from our study on the novel role of Pelo in 
maturation of profilaggrin, we theorize the importance of screening for PELO mutations in 
patients with isolated IV and atopic dermatitis-associated IV whom do not show any mutations in 
the FLG. We expect that PELO null mutations will lead to miscarriage as we showed the 
importance of in Pelo early embryonic development and inner cell mass differentiation (Adham 
et al. 2003; Nyamsuren et al. 2014). We speculate that hypomorphic mutations in PELO could 
lead to ichthyosis disease. Patients with well-characterized mutations can be permanently cured 
using the ex-vivo gene therapy. Droz-Georget Lathion et al. (2015) created a new strategy for a 
safe ex-vivo gene therapy that permits transplantation of a clonal population of genetically 
corrected autologous stem cells that meet stringent selection criteria and the principle of 
precaution. The authors chose the Human epidermal stem cells as a good model to establish their 
strategy because the human epidermal stem cells expands ex vivo efficiently and hence produce 
a large progeny from a single stem cell (Gallico et al, 1984). Moreover, they could be transduced 
efficiently by means of recombinant retrovirus to produce the protein of interest (Warrick et al. 
2012). This can open a new hope for IV patients to have a safe and homogenous medicinal 
product. 
4 Discussion  60 
 
4.4 Pelota is required for self-renewal and differentiation of embryonic stem 
cells 
Numerous studies have attempted to uncover the basic biology of the ESC and delineate 
mechanisms of pluripotency. However, many interesting challenges must be met in order to 
further understand the basic regulation of these cells. The current study introduced Pelo as a 
master regulator for a coordinated network of signaling pathways in stem cell pluripotency and 
differentiation. Here we report that Pelo-null ESCs maintain the pluripotency state under 
differentiating culture conditions.  
Previous studies in our group showed that Pelo deficiency did not markedly affect the self-
renewal of ESCs or their capacity to differentiate in teratoma assays. However, their 
differentiation into ExEn in the embryoid bodies was severely compromised. The failure of Pelo-
null ESCs to silence the pluripotency-related genes during the EB formation was attributed to 
failed signals from surrounding ExEn that induce the differentiation program (Nyamsuren et al. 
2014). That was also the case in Dido3-deficient EB where the loss of Dido3 expression delays 
primitive endoderm formation and maintains pluripotency (Fütterer et al. 2012). 
Using defined monolayer culture conditions, we demonstrated that Pelo-null ESCs retain their 
capacity to form undifferentiated dome shaped colonies and maintain expression of pluripotent 
markers under differentiation conditions. Our analysis of Pelo
Δ/−
 ESCs revealed high levels of 




Because previous studies have demonstrated the critical roles 
of PI3K/AKT in the self-renewal of ESCs (Takahashi et al. 2005; McLean 2007), we assumed 
that activation of AKT signaling supports the pluripotency of mutant ES cells and hereby affect 
the differentiation. However, addition of Wortaminin, a PI3K inhibitor, in cultures did not induce 
differentiation of the mutant ESCs judged by the ESCs morphology and with the persistent 
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expression of the pluripotent marker Oct4. These findings led us to determine other factors apart 
from PI3K/AKT that can maintain the ESCs pluripotency.  
On the other hand addition of Retonic acid induced complete differentiation of Pelo-mutant 
ESCs. RA is known in the literature as a potent differentiation agent. In contrast, retinol, which is 
the precursor of RA, was found to maintain the ESC self-renewal by elevating the expression of 
Nanog (Chen et al. 2007). Later, it was described that retinol maintains the pluripotency of ES 
cells through activation of PI3K/AKT in an insulin-like growth factor I (IGF-1) receptor/insulin 
receptor substrate 1(IRS-1)-dependent manner (Chen and Khillan 2010). Analysis of ESCs 
revealed that these cells are unable to metabolize retinol to retinoic acid due to lack of retinol 
metabolizing machinery in the ESCs. This result was further supported by the observations that 
addition of retinoic acid leads to their complete differentiation (Chen  and Khillan 2008). In 
absence of LIF, ESCs are capable of synthesizing active retinoids (4-hydroxyretinol and 4-
oxoretinol) from retinol. These retinoids can activate transcription through the retinoic acid 
receptors (RARs), leading to ESCs differentiation without forming retinoic acid (Lane et al. 
1999). Based on these information, we speculate that Pelo
Δ/−
 ESCs fail to metabolize retinol to 
active retinoids in differentiating culture conditions. Therefore, accumulation of retinol in Pelo-
mutant ESCs may be responsible for maintaining the ESCs pluripotency. To prove this 
speculation we checked the expression of stra8 gene, as its promoter region contains RA 
response elements, suggesting that RA could be turning on this gene directly (Zhou et al. 2008). 
Expression analysis of stra8 mRNA in Pelo
Δ/−
 ESCs were significantly lower than that in control 
ESCs in undifferentiated state as well as after inducing differentiation. These results confirm our 
assumption that retinol metabolism in Pelo-mutant ESCs is affected. 
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Recent study by Obrochta et al. (2015) linked the activity of Foxo1to retinol metabolism. 
Thus, cis-acting elements of Foxo1 have been identified in the promoters of genes associated 
with retinoid metabolism, including retinol dehydrogenases (RDH). The authors showed that 
enhancing the activity of PI3K/AKT signaling pathway decreases the transcription activity of 
Foxo1, followed by repression of RDH transcription, leading to decrease in retinoic acid 
synthesis from retinol. 
Although AKT activity enhance the nuclear export of phosphorylated FOXO proteins and 
hereby inhibit their transcriptional activity (Figure 20) (Van den Berg & Burgering 2011), our 
protein blot analysis revealed a significant increase in the levels of nuclear Foxo1in Pelo-mutant 
ESCs. This result corresponds to Zhang et al. (2011) findings, which highlighted the essential 
role of Foxo1 in maintaining ESCs pluripotency through direct control of Oct4 and Sox2 
expression. Despite enhanced activity of PI3K\AKT signaling pathway, Foxo1 was nuclear and 
transcriptionally active concluding that PI3K\AKT signaling pathway is not the predominant 
regulator of Foxo1 in ESCs. Other study presumed that Foxo1 inhibition by pAKT is overridden 
by other signaling pathways (Yamagata et al. 2008). 
 
Figure 20. Model of FOXO regulation by PI3K\AKT signaling pathway. Phosphorylated AKT 
phosphorylates FOXO transcription factors leading to nuclear export and inactivation of transcriptional 
activity by FOXO. 
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Therefore, we were interested to have a more detailed insight about the effect of increased 
transcription activity of Foxo1 in Pelo-null ESCs. The association of Foxo proteins with β-
catenin was elucidated by Almeida  et al. (2007). The same group in 2013 provided genetic 
evidence that FOXOs do indeed bind with β-catenin diverting the limited pool of β-catenin from 
Wnt/TCF to FOXO mediated transcription resulting in attenuation of β-catenin/TCF 
transcription in murine osteoblast progenitors (Figure 21). Generally Wnt binding to the 
Frizzled-LRP5/6 receptor complex halting the proteolytic destruction of β-catenin, which then 
moves into the nucleus where it binds to and activates the T cell factor (TCF) lymphoid-enhancer 
binding factor (LEF) transcription factors and regulates the expression of Wnt-target genes 
(Figure 21) (Rodda and McMahon 2006). The binding of FOXOs to β-catenin mechanism, 
restrain the proliferative effects of Wnt signaling. Suppression of the proliferative β-catenin/TCF 
transcriptional signal by FOXOs is probably a defense mechanism against diverse stress stimuli 
in many tissues, as evidenced by the increased association of β-catenin with FOXOs in H2O2-
treated bone and colon cancer cells (Hoogeboom et al. 2008). 
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Figure 21. Model for binding of FOXOs to β-catenin in ESCs. In presence of Pelo (right panel) 
binding of Wnt ligand to a Frizzled/LRP-5/6 receptor complex (right panel) leads to stabilization of 
hypophosphorylated β-catenin, which interacts with TCF/LEF proteins in the nucleus and regulates Wnt-
target genes transcription. In the absence of Pelo (left panel), β-catenin tends to bind to nuclear Foxo1 
diverting β-catenin from β-catenin/TCF target genes transcription (Adapted from Sun 2010). 
 
In Regards to these literatures and to our results that showed increased levels of Foxo1 in 
Pelo-null ESCs. We hypothesized that in ESCs upon Pelo deletion Foxo1 diverts β-catenin from 
TCF/LEF leading to attenuation of β-catenin/TCF transcription activity and altering Foxo-
mediated transcription (Figure 22). This hypothesis is supported by our pervious results that 
related the decreased proliferative capacity of Pelo-mutant ESCs to low levels of c-Myc, a 
candidate for β-catenin/TCF transcription activity, as well as by the significant decrease of 
TCF/LEF transcription activity in Pelo-mutant ESCs as judged by TOP/FOP-FlASH reporter 
assay.  




Figure 22. Model of Mechanisms that contribute to Pelo-null ESCs pluripotency. Pelo deletion 
increases AKT activity, Foxo1escapes the inhibitory effect of pAKT and remain nuclear. Activity of 
Foxo1 maintains the ESCs pleuripotency and decreases β-catenin/TCF-mediated transcription. This 
disrupts the RDH expression and thereby blocks the metabolism of retinol to active retinoids, which 
induce ESCs differentiation in absence of LIF. Retinol also contributes to ESCs pluripotency and lack of 
differentiation. (Adapted from Obrochta et al. 2015). 
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5. Summary 
The skin acts as a first protective barrier that diminishes the fluid loss from the body and 
prevents the entry of toxic and pathogenic agents. Defect in the formation of the epidermal 
barrier results in neonatal lethality and increased susceptibility to skin inflammation. Here, we 
show that temporal depletion of Pelota (Pelo) during embryonic development disrupts the 
acquisition of epidermal barrier. The defective function of epidermal barrier in Pelo-deficient 
mice is a result of failed processing of profilaggrin into filaggrin monomers, which promote the 
formation of protective epidermal layer. Expression analysis revealed that the expression pattern 
of Pelo correlates with the epidermal barrier formation and resemble that of pSmad and pAKT. 
Further experiments showed that Pelo negatively regulates BMP-PI3K/AKT signaling pathways. 
Hence activation of BMP-PI3K/AKT was the underlying cause for the perturbed function of 
Pelo-deficient epidermis.  
Inhibition of PI3K/AKT and BMP signaling pathways by addition of PI3K inhibitor and 
Noggin respectively, in organotypic culture of mutant and control skin explants revealed that 
attenuated activity of PI3K/AKT did not significantly affect the BMP activity. In contrast, 
inhibition of BMP signaling resulted in a significant decrease in the PI3K/AKT activity in 
mutant skin and interestingly the restoration of the profilaggrin processing and the epidermal 
barrier function. 
In adult mice, deletion of Pelo resulted in epidermal hyperproliferation, abnormal 
differentiation of keratinocytes and cutaneous inflammation. These phenotypes are often 
associated with epidermal barrier dysfunction. To determine whether these symptoms are due to 
systemic immune-system disorder or a result of affected skin barrier, Pelo was topically deleted 
in a small region of the tail skin. Histological analyses revealed that hyperkeratosis and increased 
infiltration of mast cells were only restricted to the topically Pelo-deficient skin region and the 
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other skin areas were completely normal. Additionally, our results showed the perturbation of the 
epidermal barrier function in Pelo-null skin explants grown in vitro providing strong evidence 
that the barrier defect was not due to systemic effect of Pelo deletion, but due to skin-
autonomous effect. 
These results point out that Pelo is a novel modulator of the BMP-PI3K/AKT signaling axis 
which promotes the maturation of profilaggrin to ensure epidermal barrier formation. 
In the second part of the study, we investigated the molecular causes for attenuated rate of 
cell proliferation and impaired differentiation of Pelo-deficient ESCs. We found that the elevated 
activity of PI3K/AKT signaling is not the cause for impaired differentiation of Pelo-null ESCs. 
Despite the enhanced activity of PI3K/AKT in Pelo-null ESCs, Foxo1 escapes the inhibitory 
effect of PI3K/AKT signaling and retain in the nucleus. Nuclear Foxo1 tends to divert β-catenin 
from binding TCF and hereby restrain the WNT/TCF activity.  
Induction of ESC differentiation by retinoic acid (RA) led us to suggest that retinol 
metabolism in Pelo mutant ESCs is disrupted. As RDH is one targets of Foxo1, we assumed that 
the binding of Foxo1to β-catenin on one hand decreased the proliferative effect of Wnt signaling 
pathway and on the other hand altered the Foxo1 transcription activity. Therefore, the RDH 
transcription was affected resulting in defect in retinol metabolism to active retinoids, and 
probably this was the underlying cause for impaired differentiation of Pelo-mutant ESCs in 
absence of LIF. 
 Extending the study on role of Pelo in ESCs self-renewal and differentiation would add valuable 
information about the role of PELO during early embryonic development, Moreover this 
knowledge may be used for improving somatic cell reprogramming as well.
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